2 results match your criteria: "Hospital General University Elche[Affiliation]"
Multiple vertebral fractures after suspension of denosumab. A series of 56 cases.
Int J Clin Pract
October 2021
Internal Medicine Service, Hospital Virgen de la Luz, Cuenca, Spain.
Article Synopsis
- Denosumab is a medication for postmenopausal osteoporosis, but stopping it can lead to a rapid decline in bone density and increase the risk of multiple vertebral fractures (MVF).
- This study analyzed 56 postmenopausal women who suffered MVFs after discontinuing denosumab, focusing on their clinical and biochemical profiles and identifying factors linked to more fractures.
- Results showed 192 new vertebral fractures, with most patients having no prior fractures; the duration of denosumab use was the only significant factor tied to a higher number of fractures after stopping the drug.
Patent processus vaginalis in peritoneal dialysis.
Kidney Int
September 2013
Section of Nephrology, Hospital General University Elche, Elche, Spain.